Isavuconazole in the Treatment of Chronic Forms of Coccidioidomycosis

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..

Coccidioidomycosis is a fungal infection with a range of clinical manifestations. Currently used antifungal agents exhibit variable efficacy and toxicity profiles that necessitate evaluation of additional therapeutic options. Improvement was observed in the majority of patients treated with isavuconazole, with clinical failures observed only in those with coccidioidal meningitis.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:76

Enthalten in:

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 76(2023), 12 vom: 16. Juni, Seite 2196-2199

Sprache:

Englisch

Beteiligte Personen:

Heidari, Arash [VerfasserIn]
Sharma, Rupam [VerfasserIn]
Shakir, Qusai [VerfasserIn]
Shah, Madiha [VerfasserIn]
Clement, Josh [VerfasserIn]
Donnelley, Monica A [VerfasserIn]
Reynolds, Trina [VerfasserIn]
Trigg, Kate [VerfasserIn]
Jolliff, Jeff [VerfasserIn]
Kuran, Rasha [VerfasserIn]
Johnson, Royce [VerfasserIn]
Thompson, George R [VerfasserIn]

Links:

Volltext

Themen:

60UTO373KE
Antifungal
Antifungal Agents
Coccidioides
Isavuconazole
Isavuconazonium
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Treatment
Triazoles
Valley fever

Anmerkungen:

Date Completed 19.06.2023

Date Revised 27.02.2024

published: Print

Citation Status MEDLINE

doi:

10.1093/cid/ciad146

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM354107879